Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Voodoo Volleyball bounces back in OP: Father-daughter duo doubles as new venture’s setters
Quinn Austin put several sports to the test as a preteen — racing from basketball practice to softball to volleyball. But she latched on to just one. “Volleyball. It was my sport. Everyone was having a good time,” she said. “We just loved the cheers — a cheer when we got a hit, a cheer…
Black farmers are losing ground in the fight to feed their communities, advocates say
More than a century of systemic land dispossession and discriminatory practices has left Black farmers with less than 0.6 percent of U.S. farmland — less than a third of the 16 million acres they operated in 1910, according to local urban farming advocates. They gathered Tuesday at Independence Boulevard Christian Church to confront this history…
Cracking egg-flation: How farmers, substitute ingredients help restaurants mitigate price spike
Editor’s note: This story was originally published by Kansas City PBS/Flatland, a member of the Kansas City Media Collective, which also includes Startland News, KCUR 89.3, American Public Square, The Kansas City Beacon, and Missouri Business Alert. Click here to read the original story. Whether ordering an omelet, French toast, chicken n’ biscuits, chilaquiles, corned beef hash…
Soccer tennis comes to KC ahead of World Cup; here’s how a weekend street festival is kicking it across the map
Ryogoku Soccer Academy — with the help of local businesses like MADE MOBB, Café Ollama, and Café Cà Phê — is taking soccer from the pitch to the streets of Kansas City’s historic Northeast, Brad Leonard shared. As the metro gears up for hosting World Cup games in 2026, the neighborhood-based international school and soccer…